Dimensional Fund Advisors
WINT

Dimensional Fund Advisors’s Windtree Therapeutics Inc WINT Stock Holding History

Dimensional Fund Advisors’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,891
Closed -$31K – 3454
2014
Q4 		$31K Hold
1,891
– – ﹤0.01% 3399
2014
Q3 		$49K Hold
1,891
– – ﹤0.01% 3397
2014
Q2 		$47K Hold
1,891
– – ﹤0.01% 3441
2014
Q1 		$57K Hold
1,891
– – ﹤0.01% 3441
2013
Q4 		$60K Hold
1,891
– – ﹤0.01% 3402
2013
Q3 		$52K Sell
1,891
-594
-24% -$14.4K ﹤0.01% 3446
2013
Q2 		$53K Buy
+2,485
New +$61.2K ﹤0.01% 3436

Other funds holding WINT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Dimensional Fund Advisors's WINT Position: Q1 2015 in Review

Dimensional Fund Advisors sold out of Windtree Therapeutics Inc (WINT) in Q1 2015, closing a stake of 1,891 shares — an estimated $31K sold.

Dimensional Fund Advisors first reported a position in WINT in Q2 2013 and held it in 7 quarters. The position peaked at $60K in Q4 2013. 58 funds tracked by Wall St. Rank hold WINT as of Q1 2015.

  • Dimensional Fund Advisors reported no remaining Windtree Therapeutics Inc position as of Q1 2015 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,891 Windtree Therapeutics Inc shares in Q1 2015, an estimated $31K.
  • Dimensional Fund Advisors first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 7 quarters.
  • Dimensional Fund Advisors's Windtree Therapeutics Inc position peaked at $60K in Q4 2013.
  • 58 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q1 2015.

Based on Dimensional Fund Advisors's 13F filing for Q1 2015, filed 14 May 2015.